Vlad the Inhaler is a modern hybrid cannabis strain derived from its parent, Stoopid Fruits. Designed for the contemporary cultivator, this variety thrives in both indoor and outdoor environments, requiring a moderate level of expertise to manage its development. Growers can expect a high yield from this plant, which reaches maturity following a flowering cycle of 63 days. Its genetic impact is perhaps most clearly demonstrated by its role as a parent to the notable offspring Black Lily.

The chemical expression of Vlad the Inhaler is defined by a complex terpene profile dominated by myrcene, followed by caryophyllene, bisabolol, and limonene. Secondary and tertiary contributions from linalool, humulene, terpinolene, and beta-pinene round out the aromatic and flavor landscape. This specific composition dictates the strain’s sensory experience, blending these distinct compounds to reflect its unique genetic background.

As a THC-dominant hybrid, Vlad the Inhaler is primarily utilized for its relaxed, happy, and uplifted effects. These properties make it a frequent choice for users seeking support in managing stress, physical pain, and sleep difficulties. Through its stable genetic profile and consistent performance, the strain continues to influence current breeding programs, specifically through the established pedigree of its progeny.